The preoccupation the medical and scientific communities have with cholesterol have convinced many of us, doctors included, that ‘cholesterol is bad’ so ‘cholesterol reduction is good’. But, as I’ve pointed out before, even if cholesterol does jeopardise health, the fact that something reduces cholesterol does not make it inherently healthy. Even if arsenic and cyanide were found to be effective cholesterol-reducing agents, it wouldn’t make sense to swig back these poisons each day, would it?
If this notion seems far-fetched, consider the fact that the cholesterol-improver torcetrapib had to be pulled from development when it was discovered to be killing people. The effects on health are the key thing, not its effects on cholesterol. Failure of regulators to focus on this critical distinction is how we have governments spending money on a drug called ezetimibe which reduces cholesterol but has never been shown to have benefits for health and has been linked with an increased risk of death from cancer.
Another class of drug that requires some scrutiny, I think, is the ‘fibrates’ such as clofibrate, gemfibrozil and fenofibrate.
Continue reading the article here: http://www.drbriffa.com/2012/